NHS to expand use of University of Oxford’s OpenSAFELY secure COVID-19 research platform to help find new treatments for major killer conditions
20 November 2023
The NHS is to expand the use of the OpenSAFELY research platform, behind the roll-out of new Covid-19 treatments, to help drive life-saving advances for other major diseases.
22 August 2023
People at risk of severe respiratory illnesses will have access to the to the newest and fastest technology currently available to assess them for Chronic Obstructive Pulmonary Disease (COPD), an incurable medical condition affecting over 1.2 million people in the UK.
New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years.
6 April 2023
A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.
15 February 2023
People with blood cancers are among the most clinically vulnerable individuals to COVID-19 in the UK, and a new analysis of over 12 million patient health records has revealed inequalities in COVID-19 vaccine uptake among this group.
2 November 2022
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates.
24 June 2022
The Society for Academic Primary Care (SAPC) and the RCGP Scientific Foundation Board (SFB) award two departmental members for their contribution: Senior Clinical Research Fellow, Dr. Oliver van Hecke, receives SAPC/RCGP award for Outstanding Early Career Researcher 2022, and undergraduate medical student, Hettie Davies, receives the SAPC Medical Student Essay Prize 2022.
12 April 2022
From today, the antiviral treatment Paxlovid has been included in the national PANORAMIC study, the UK’s fastest ever recruiting clinical trial of its kind, run by the Nuffield Department of Primary Care Health Sciences and supported by the National Institute for Health and Care research (NIHR).
'Goldacre Recommendations' to Drive Innovation and Improve Healthcare Through Safer Use of Health Data Published
7 April 2022
Professor Ben Goldacre publishes findings from an independent review to improve use of health data in NHS. Recommendations include increasing transparency and modernising software infrastructure to boost research whilst maintaining high security standards. The findings have already helped shape the Health and Social Care Data Strategy, being published later this year, which will set out a vision to make better use of data to save lives.
30 March 2022
About one in three people get shingles, which causes a painful rash. Researchers are recruiting patients with newly diagnosed shingles into a new study, to see if they can prevent the long-term pain which commonly persists after the rash has healed.
Oxford launches new Bennett Institute for Applied Data Science and Ben Goldacre announced as the first Bennett Professor of Evidence-Based Medicine
23 March 2022
The use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
Professor Julia Hippisley-Cox and her team have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
20 September 2021
New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
16 September 2021
The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes. The Institute has been made possible due to a generous donation from The Peter Bennett Foundation
Department cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
2 September 2021
The research, led by researchers at the Nuffield Department of Primary Care Health Sciences, is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as “cutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.”
27 August 2021
Oxford researchers have today announced the results of a blood clot study, suggesting lower risk with vaccine than infection.
10 August 2021
Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.
15 July 2021
The results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.
15 July 2021
The QCovid®-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.